Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Acquired Bernard-Soulier-like syndrome due to a plasma-based inhibitor treated successfully with rituximab.
Journal: Research and practice in thrombosis and haemostasis
Published: July 12, 2024
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 09, 2024
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 09, 2017
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
Journal: British journal of haematology
Published: September 27, 2015
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2014
Showing 1-5 of 5
Last Updated: 09/26/2026